3.4 Massive Hemoptysis, Complex Pleural Effusions & Thoracic Drainage

Thoracic emergencies involving the conducting airways, pulmonary vasculature, and pleural space are frequent sources of acute respiratory decompensation in the ICU. Life-threatening hemoptysis, loculated parapneumonic effusions, empyema, and tension pneumothorax require swift clinical recognition, mastery of invasive diagnostic testing, and immediate procedural interventions.

---

Massive Hemoptysis: Pathophysiology & Vascular Origins

Definition and Clinical Significance

Massive (life-threatening) hemoptysis is defined clinically as any rate of hemoptysis that impairs gas exchange, causes upper airway obstruction, or produces hemodynamic instability, regardless of measured volume. Quantitatively, it is traditionally defined as bleeding exceeding 100 to 600 mL within a 24-hour period (or $>150\text{ mL/hour}$).

Dual Vascular Supply of the Lung

In chronic inflammatory lung diseases, angiogenesis driven by vascular endothelial growth factor (VEGF) induces extensive proliferation of tortuous, thin-walled, fragile bronchial arteries. These systemic-pressure vessels readily rupture under high shear stress or active infection.

---

Immediate Emergency Management of Massive Hemoptysis

Immediate Management Algorithm for Massive Hemoptysis:

                    MASSIVE HEMOPTYSIS ENCOUNTERED
                                  │
                                  ▼
   STEP 1: POSITIONING
   • Place patient in LATERAL DECUBITUS position with BLEEDING LUNG DEPENDENT
   • Prevents blood from spilling into and drowning the healthy contralateral lung
                                  │
                                  ▼
   STEP 2: AIRWAY PROTECTION & RESUSCITATION
   • High-flow oxygen / prepare for immediate intubation
   • Intubate with LARGE-BORE single-lumen ETT (≥8.0–8.5 mm)
   • Large caliber allows passage of therapeutic flexible bronchoscope (5.9–6.3 mm)
   • Preload with crystalloid, initiate massive transfusion protocol if coagulopathic
                                  │
                                  ▼
   STEP 3: LOCALIZATION & ENDOBRONCHIAL TAMPONADE
   • Urgent flexible bronchoscopy in ICU:
     - Iced saline lavage (50 mL aliquots at 4°C)
     - Topical tranexamic acid (500–1,000 mg endobronchial)
     - Topical epinephrine (1:20,000 or 1:100,000 dilution)
     - Advance endobronchial blocker (Fogarty catheter) into bleeding bronchus
   • Alternatively: Selective mainstem intubation of the healthy lung
                                  │
                                  ▼
   STEP 4: DEFINITIVE ANGIOGRAPHIC EMBOLIZATION
   • Emergent Catheter Angiography & Bronchial Artery Embolization (BAE)
   • Embolize abnormal systemic vessels with microparticles
   • CRITICAL: Identify and avoid the Artery of Adamkiewicz (spinal ischemia risk)

Airway Management Nuances

• Single-Lumen vs. Double-Lumen Tube (DLT): While a DLT allows complete anatomical lung separation, its placement in an actively hemorrhaging, coughing patient is technically challenging and frequently impossible. Furthermore, each lumen of a DLT is narrow ($~4\text{ mm}$), preventing passage of a standard therapeutic flexible bronchoscope and becoming rapidly occluded by thick clots. Therefore, a large single-lumen tube ($\ge 8.0–8.5\text{ mm}$) is the standard of care in the ICU, combined with an endobronchial blocker or selective right/left mainstem intubation under direct bronchoscopic visualization.

Definitive Intervention: Bronchial Artery Embolization (BAE)

Emergent transcatheter bronchial artery embolization (BAE) performed by interventional radiology is the definitive first-line procedure for massive hemoptysis, achieving acute hemostasis in $>85–90\%$ of cases.

Angiography identifies hypertrophied, tortuous bronchial arteries, systemic-to-pulmonary shunts, and contrast extravasation. Embolization is accomplished using polyvinyl alcohol (PVA) particles ($300–500\ \mu\text{m}$) or microspheres.

---

Complex Pleural Effusions & Empyema

Diagnostic Thoracentesis & Light's Criteria

Diagnostic thoracentesis should be performed promptly for any unexplained pleural collection $>10\text{ mm}$ thickness on decubitus radiography or thoracic ultrasonography. Fluid is analyzed to differentiate an exudate from a transudate using Light's criteria:

Light's Criteria for Exudative Pleural Effusion:
(Effusion is an EXUDATE if at least ONE of the following is present):
├── 1. Pleural fluid protein / Serum protein ratio > 0.5
├── 2. Pleural fluid LDH / Serum LDH ratio > 0.6
└── 3. Pleural fluid LDH > 2/3 the upper limit of normal laboratory serum LDH

Staging Parapneumonic Effusions

Parapneumonic effusions progress through three continuous stages: exudative (simple), fibropurulent (complicated), and organizational (empyema).

The MIST-2 Trial Protocol for Loculated Empyema

When complicated effusions or empyemas develop dense fibrin septations and loculations, standard chest tube drainage often fails because the fluid cannot navigate the loculated pockets.

The landmark MIST-2 Trial (Second Multicentre Intrapleural Sepsis Trial, NEJM 2011) evaluated 210 patients with pleural infection randomized to four arms: intrapleural tPA plus DNase, tPA alone, DNase alone, or double placebo:

• The Regimen:
  • Tissue Plasminogen Activator (Alteplase / tPA): 10 mg instilled intrapleurally.
  • Human Recombinant Deoxyribonuclease (DNase / Pulmozyme): 5 mg instilled intrapleurally.
  • Both agents administered concurrently twice daily for 3 days (total of 6 doses).
  • Following instillation, the chest tube is clamped for 1 to 2 hours to allow enzyme activity before unclamping to continuous negative suction ($-20\text{ cmH}_2\text{O}$).
• Mechanistic Synergy: tPA breaks down the thick fibrin meshwork of loculations, while DNase hydrolyzes free extracellular DNA released by lysed neutrophils, dramatically lowering fluid viscosity.
• Outcomes: The combined tPA/DNase protocol produced a marked, statistically significant reduction in radiographic pleural opacity ($p < 0.001$), reduced the need for surgical rescue (video-assisted thoracoscopic surgery [VATS] or open thoracotomy) by 75% (odds ratio 0.17, $p = 0.03$; a secondary outcome), and shortened hospital stay by an average of 6.7 days. Monotherapy with tPA alone or DNase alone showed no clinical benefit over placebo.

---

Tension Pneumothorax & Thoracic Drainage Principles

Pathophysiology of Tension Pneumothorax

Tension pneumothorax develops when a one-way tissue valve allows atmospheric or positive-pressure gas to enter the pleural space during inspiration without escape during expiration. Progressive intrapleural air accumulation causes intrapleural pressure to exceed ambient atmospheric and central venous pressures, with rapid catastrophic results:

                  One-Way Pleural Valve Air Leak
                                │
                                ▼
             Massive Positive Intrapleural Pressure
                                │
                                ▼
               Total Collapse of Ipsilateral Lung
                                │
                                ▼
           Mediastinal Shift to the Contralateral Hemithorax
                                │
                                ▼
       Torsion and Compression of Superior & Inferior Vena Cava
                                │
                                ▼
          Acute Reduction in Right Atrial Venous Return
                                │
                                ▼
            Obstructive Shock & Imminent Cardiac Arrest

Clinical Presentation & Emergency Management

• Diagnosis is Entirely Clinical: Marked tachypnea, severe respiratory distress, acute cyanosis, hypotension, tachycardia, ipsilateral absent breath sounds, hyperresonance to percussion, distended neck veins, and contralateral tracheal deviation. Never delay intervention to obtain a confirmatory chest radiograph in an unstable patient!
• Emergent Needle Decompression:
  • Insert a large-bore (14-gauge or 16-gauge, $\ge 5–8\text{ cm}$ length) needle catheter:
    • Second intercostal space at the midclavicular line, immediately superior to the third rib (to avoid the intercostal neurovascular bundle running along the inferior rib groove).
    • Alternatively: Fourth or fifth intercostal space at the anterior axillary line (frequently preferred in muscular or obese patients due to thinner chest wall anatomy).
• Tube Thoracostomy: Needle decompression must be followed immediately by formal tube thoracostomy (chest tube, typically $24–28\text{ French}$ for hemothorax/trauma, or $14–20\text{ French}$ for simple pneumothorax) connected to a three-chamber water seal suction apparatus.

Mechanics of the Three-Chamber Drainage System

                        Three-Chamber Pleural Drainage System
                                         │
        ┌────────────────────────────────┼────────────────────────────────┐
        ▼                                ▼                                ▼
1. Collection Chamber            2. Water Seal Chamber           3. Suction Control Chamber
• Receives fluid/blood           • Acts as a one-way valve       • Governs applied suction
• Calibrated volume measurement  • Allows air to escape; prevents (typically -20 cmH2O)
• Monitored for hourly output      ambient air from re-entering  • Bubbling confirms suction
                                 • Continuous bubbling indicates   level is actively driven
                                   persistent air leak (fistula)

• Evaluating Air Leaks: Continuous bubbling in the water seal chamber during both inspiration and expiration indicates an active, persistent bronchopleural fistula or an external leak in the tubing circuit. Bubbling that occurs only during expiration or coughing indicates a resolving air leak as the lung re-expands.